MedTrace Logo

Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin

NCT05203354 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-01-24

No results posted yet for this study

Summary

Studying the effects of Narrowband Ultraviolet B versus acitretin on psoriatic patients

Conditions

Interventions

RADIATION

Narrowband Ultraviolet B

patients will exposed to sessions of NB-UVB phototherapy twice weekly for 3 months

DRUG

Acitretin

patients will received acitretin in dose 0.5-1 mg/kg daily for 3 months

Sponsors & Collaborators

  • Mahmoud Ahmed Ali Ahmed

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2021-05-01
Completion
2021-08-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05203354 on ClinicalTrials.gov